A new study suggests that Merck’s cervical cancer vaccine, Gardasil, was more cost effective than the popularly used Cervarix

However the new study by Health Protection Agency (HPA) suggests that it is Gardasil that provides a more cost effective service compared to Cervarix.
The study said that while both the vaccines were effective against HPV types 16 and 18, Gardasil also provided protection against types 6 and 11. The researchers said that this made Gardasil a better prospect compared to Cervarix.
Source-Medindia